,Set,NGenes,Direction,PValue,FDR
1,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.000212277606568309,0.175129025418855
2,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,26,Up,0.000480645495024459,0.198266266697589
3,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.00134573679771804,0.344222281957542
4,WP_HYPERTROPHY_MODEL,13,Down,0.00188390959169154,0.344222281957542
5,WP_NETRINUNC5B_SIGNALING,35,Down,0.00234567725520607,0.344222281957542
6,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Down,0.00250343477787303,0.344222281957542
7,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,104,Down,0.00353504621179948,0.366363949878117
8,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,18,Down,0.00355262012003023,0.366363949878117
9,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Down,0.00405976200665026,0.368213781082099
10,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.00446319734644968,0.368213781082099
11,WP_ALLOGRAFT_REJECTION,50,Down,0.00622536875051584,0.408229604257045
12,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.00658371762471146,0.408229604257045
13,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,26,Down,0.00705202986679328,0.408229604257045
14,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,28,Down,0.00740011058500032,0.408229604257045
15,WP_TYPE_II_INTERFERON_SIGNALING,31,Up,0.00798387563503832,0.408229604257045
16,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,13,Down,0.00800940807899395,0.408229604257045
17,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.00884087500218226,0.408229604257045
18,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.00890682772924462,0.408229604257045
19,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,7,Down,0.00958638575256129,0.409053423889246
20,WP_GPR40_PATHWAY,7,Down,0.0101640077773245,0.409053423889246
21,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Down,0.0104122689717263,0.409053423889246
22,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.0116019672544703,0.413067490040587
23,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,10,Down,0.0121418768275546,0.413067490040587
24,WP_ASPIRIN_AND_MIRNAS,8,Down,0.0124212957170038,0.413067490040587
25,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.0137359403299396,0.413067490040587
26,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.0147662442242159,0.413067490040587
27,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,11,Down,0.0148238220697881,0.413067490040587
28,WP_POSTCOVID_NEUROINFLAMMATION,13,Down,0.0151657461638985,0.413067490040587
29,WP_TCELL_RECEPTOR_SIGNALING,73,Down,0.0164364521371786,0.413067490040587
30,WP_MAPK_SIGNALING,157,Down,0.0167668720936964,0.413067490040587
31,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.0170769241412141,0.413067490040587
32,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,3,Down,0.0173089580267747,0.413067490040587
33,WP_GPCRS_OTHER,13,Down,0.0174071112515902,0.413067490040587
34,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.0179943716773568,0.413067490040587
35,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Up,0.0180432625186166,0.413067490040587
36,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.0183439127899761,0.413067490040587
37,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,10,Down,0.0186680799538756,0.413067490040587
38,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.0190261389352028,0.413067490040587
39,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.0205229742678209,0.423540310411335
40,WP_OREXIN_RECEPTOR_PATHWAY,112,Down,0.0205352877775193,0.423540310411335
41,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.0215898923538896,0.425835753086531
42,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Down,0.0216789110662234,0.425835753086531
43,WP_ACE_INHIBITOR_PATHWAY,4,Down,0.0233414442873385,0.439974942124391
44,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.0236614939073345,0.439974942124391
45,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.023998633206785,0.439974942124391
46,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,44,Down,0.026456826967572,0.464491667920081
47,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.0264619495663561,0.464491667920081
48,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.0275553027569857,0.469033229350797
49,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Down,0.0278577311978049,0.469033229350797
50,WP_SPINAL_CORD_INJURY,64,Down,0.0295163581256547,0.472874157296626
51,WP_EGFEGFR_SIGNALING,138,Down,0.0297012504772189,0.472874157296626
52,WP_TRANSLATION_FACTORS,49,Down,0.0306639860964175,0.472874157296626
53,WP_ERBB_SIGNALING,68,Down,0.0307928856889945,0.472874157296626
54,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.0309517630230519,0.472874157296626
55,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.0327821428159335,0.485039471818062
56,WP_NEURAL_CREST_DIFFERENTIATION,34,Down,0.0330448188898723,0.485039471818062
57,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,62,Down,0.0346522730390354,0.485039471818062
58,WP_CREATINE_PATHWAY,2,Down,0.0346796160957495,0.485039471818062
59,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.0346876713178978,0.485039471818062
60,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,15,Down,0.0359344686520384,0.494098943965527
61,WP_VITAMIN_B12_DISORDERS,9,Up,0.0366882823527886,0.496193982640174
62,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Down,0.0386658399320265,0.499463840458714
63,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.038746285805282,0.499463840458714
64,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.038746285805282,0.499463840458714
65,WP_KETOGENESIS_AND_KETOLYSIS,5,Up,0.0409734494875394,0.517038645091357
66,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.0413630916073086,0.517038645091357
67,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.0421682014765761,0.519235316689183
68,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.0443644606797703,0.538245295011919
69,WP_COMPLEMENT_ACTIVATION,11,Down,0.0454238795521331,0.543111603340722
70,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,76,Down,0.0483823951382027,0.55980040742874
71,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.048903276450434,0.55980040742874
72,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,13,Up,0.0494815595091131,0.55980040742874
73,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.0495338542330885,0.55980040742874
74,WP_RANKLRANK_SIGNALING,47,Down,0.0503731326560374,0.561592357313931
75,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.0544289775497847,0.586936112431344
76,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,101,Down,0.0546622811599513,0.586936112431344
77,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,13,Up,0.0547807038269254,0.586936112431344
78,WP_MAPK_CASCADE,30,Down,0.0560034806223282,0.586957392806651
79,WP_BURN_WOUND_HEALING,62,Down,0.0562056170081521,0.586957392806651
80,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,14,Down,0.0570809928704989,0.58864773897702
81,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.058442143972358,0.58953874887068
82,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,25,Up,0.0586434307782952,0.58953874887068
83,WP_GASTRIN_SIGNALING,91,Down,0.0593111710985048,0.58953874887068
84,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,41,Down,0.0634090201593844,0.622767162279668
85,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.0653323930508429,0.634108520787593
86,WP_OXIDATIVE_DAMAGE_RESPONSE,33,Down,0.0661237510489026,0.634326681573775
87,WP_IL1_SIGNALING,51,Down,0.0688326744638008,0.634596182520062
88,WP_ENDODERM_DIFFERENTIATION,82,Down,0.0698723604397059,0.634596182520062
89,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Up,0.0707091577095346,0.634596182520062
90,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,12,Up,0.072297953304029,0.634596182520062
91,WP_PROLACTIN_SIGNALING,70,Down,0.0725688866476673,0.634596182520062
92,WP_IRINOTECAN_PATHWAY,5,Up,0.0726282561074991,0.634596182520062
93,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,26,Down,0.0727949877220382,0.634596182520062
94,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.0737980719473009,0.634596182520062
95,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,6,Down,0.0747152380788101,0.634596182520062
96,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.0748061871598459,0.634596182520062
97,WP_PDGF_PATHWAY,36,Down,0.0761849066850629,0.634596182520062
98,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,26,Down,0.0772097985512538,0.634596182520062
99,WP_VEGFAVEGFR2_SIGNALING,338,Down,0.0783271980709087,0.634596182520062
100,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.0785052848552425,0.634596182520062
101,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Down,0.0789642813837307,0.634596182520062
102,WP_MONOAMINE_TRANSPORT,11,Down,0.079305394309066,0.634596182520062
103,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.0793102990626677,0.634596182520062
104,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.0833768247319251,0.634596182520062
105,WP_GENES_CONTROLLING_NEPHROGENESIS,12,Down,0.0841486267965357,0.634596182520062
106,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.0845334129280641,0.634596182520062
107,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.084678125951668,0.634596182520062
108,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Down,0.0848798924382334,0.634596182520062
109,WP_PURINE_METABOLISM,10,Down,0.0852928273646067,0.634596182520062
110,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Down,0.0852958140606422,0.634596182520062
111,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,16,Down,0.085382031829972,0.634596182520062
112,WP_GLIOBLASTOMA_SIGNALING,65,Down,0.0868423271501518,0.635209948459875
113,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,16,Down,0.0875337340064284,0.635209948459875
114,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.0877744656053645,0.635209948459875
115,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,12,Down,0.0892866213459058,0.640534457481498
116,WP_AXON_GUIDANCE,33,Down,0.0909743114429315,0.642650226194662
117,WP_DOPAMINERGIC_NEUROGENESIS,5,Down,0.0919002832844471,0.642650226194662
118,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.0919184565951153,0.642650226194662
119,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.0927385885090131,0.642935592604502
120,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.0938494727052496,0.645215124848591
121,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,34,Down,0.0964032286926089,0.650252012544333
122,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.0969043544321487,0.650252012544333
123,WP_GPCRS_CLASS_A_RHODOPSINLIKE,47,Down,0.0970218287448364,0.650252012544333
124,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,13,Up,0.0984361936290186,0.650252012544333
125,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,15,Up,0.101635886150128,0.650252012544333
126,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,163,Down,0.102537216882752,0.650252012544333
127,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.102615917446817,0.650252012544333
128,WP_TP53_NETWORK,14,Down,0.102801431257194,0.650252012544333
129,WP_IL18_SIGNALING,190,Down,0.10323954383017,0.650252012544333
130,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,27,Up,0.103812032710798,0.650252012544333
131,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Up,0.104947181898987,0.650252012544333
132,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,30,Down,0.106242115727865,0.650252012544333
133,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,36,Up,0.106764193966441,0.650252012544333
134,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Down,0.106893867048682,0.650252012544333
135,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,20,Down,0.10695323482429,0.650252012544333
136,WP_ALPHA_6_BETA_4_SIGNALING,24,Down,0.107518142168673,0.650252012544333
137,WP_NAD_METABOLISM,11,Down,0.107981243295241,0.650252012544333
138,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.110426260112208,0.651581604101489
139,WP_AGERAGE_PATHWAY,55,Down,0.111951365104092,0.651581604101489
140,WP_B_CELL_RECEPTOR_SIGNALING,87,Down,0.11228400226384,0.651581604101489
141,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.112483169106678,0.651581604101489
142,WP_NRXN1_DELETION_SYNDROME,2,Down,0.11303752452348,0.651581604101489
143,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Down,0.113406750312591,0.651581604101489
144,WP_MICROTUBULE_CYTOSKELETON_REGULATION,34,Down,0.113730607261351,0.651581604101489
145,WP_PLEURAL_MESOTHELIOMA,246,Down,0.114913802410305,0.651785668245231
146,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.115943547254803,0.651785668245231
147,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.117324964736718,0.651785668245231
148,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.118177758009008,0.651785668245231
149,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,9,Down,0.118397124132113,0.651785668245231
150,WP_BDNFTRKB_SIGNALING,26,Down,0.118991099513341,0.651785668245231
151,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,11,Up,0.119296528369733,0.651785668245231
152,WP_HIPPO_SIGNALING_REGULATION,41,Down,0.120871224490193,0.656044475029009
153,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.1227254869102,0.660704203073746
154,WP_KLEEFSTRA_SYNDROME,25,Down,0.123331451240433,0.660704203073746
155,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Down,0.124140281904841,0.660746661751573
156,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.126000237809605,0.666347411493102
157,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Down,0.126897450100973,0.666817811040147
158,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,27,Down,0.129267725826773,0.670217320951693
159,WP_ZINC_HOMEOSTASIS,20,Up,0.130120634459445,0.670217320951693
160,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Down,0.130804246750283,0.670217320951693
161,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,11,Down,0.131503270458142,0.670217320951693
162,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.131945537947258,0.670217320951693
163,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Down,0.13283647747443,0.670217320951693
164,WP_NRF2ARE_REGULATION,21,Up,0.133771263004139,0.670217320951693
165,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,11,Up,0.135373842416252,0.670217320951693
166,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,62,Down,0.135447273394312,0.670217320951693
167,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,22,Up,0.135668233453252,0.670217320951693
168,WP_FRAGILE_X_SYNDROME,83,Down,0.137210771357544,0.671964306395179
169,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.137679900798942,0.671964306395179
170,WP_CHEMOKINE_SIGNALING,114,Down,0.138767249949741,0.671964306395179
171,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,76,Down,0.139279874416455,0.671964306395179
172,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,19,Down,0.140240963785526,0.672667413506155
173,WP_IL10_ANTIINFLAMMATORY_SIGNALING,11,Up,0.143048251864356,0.680639493622374
174,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,20,Down,0.143553056836719,0.680639493622374
175,WP_ATR_SIGNALING,10,Up,0.144740356213365,0.68234739357729
176,WP_INSULIN_SIGNALING,126,Down,0.1473172810167,0.690549754765781
177,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,128,Up,0.150014503345651,0.698199684862744
178,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,49,Down,0.150641871400689,0.698199684862744
179,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.151521033469447,0.698351131912257
180,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.155061905101469,0.708027324583799
181,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,60,Down,0.156320834519334,0.708027324583799
182,WP_COPPER_HOMEOSTASIS,39,Up,0.157143146488783,0.708027324583799
183,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,1,Down,0.157868861192654,0.708027324583799
184,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.157911548755659,0.708027324583799
185,WP_ONCOSTATIN_M_SIGNALING,56,Down,0.159355254078074,0.710638295213032
186,WP_RAS_SIGNALING,113,Down,0.160947808197783,0.713881407328878
187,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.162525164973889,0.715265889233078
188,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,82,Down,0.164793839788694,0.715265889233078
189,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.165719904627968,0.715265889233078
190,WP_OXIDATION_BY_CYTOCHROME_P450,16,Down,0.166304809354279,0.715265889233078
191,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,11,Down,0.16669850250823,0.715265889233078
192,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.168319549783927,0.715265889233078
193,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.172013858911436,0.715265889233078
194,WP_PURINERGIC_SIGNALING,16,Down,0.173186702643296,0.715265889233078
195,WP_MTHFR_DEFICIENCY,18,Down,0.173835777960357,0.715265889233078
196,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.174823616914512,0.715265889233078
197,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.175317679347317,0.715265889233078
198,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,74,Down,0.176329428308554,0.715265889233078
199,WP_5Q35_COPY_NUMBER_VARIATION,75,Up,0.179186432441672,0.715265889233078
200,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.179390346362785,0.715265889233078
201,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,60,Down,0.179802658527192,0.715265889233078
202,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,75,Down,0.179810795551959,0.715265889233078
203,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Down,0.182045635063946,0.715265889233078
204,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,39,Down,0.182348608685738,0.715265889233078
205,WP_KIT_RECEPTOR_SIGNALING,51,Down,0.182961336659366,0.715265889233078
206,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.183299632131993,0.715265889233078
207,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,62,Down,0.183649736223659,0.715265889233078
208,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,20,Down,0.183858514784777,0.715265889233078
209,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,33,Down,0.184269117732816,0.715265889233078
210,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.18462411619277,0.715265889233078
211,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,12,Down,0.184831399573546,0.715265889233078
212,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.186034732141141,0.715265889233078
213,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.186093883105434,0.715265889233078
214,WP_G_PROTEIN_SIGNALING,60,Down,0.18622884899058,0.715265889233078
215,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Down,0.186402625678923,0.715265889233078
216,WP_VALPROIC_ACID_PATHWAY,8,Up,0.188847046741571,0.718916548473778
217,WP_DOPAMINE_METABOLISM,7,Down,0.189096837598557,0.718916548473778
218,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,8,Down,0.190561393776317,0.719735701429372
219,WP_PREIMPLANTATION_EMBRYO,20,Down,0.191057113470342,0.719735701429372
220,WP_MEASLES_VIRUS_INFECTION,99,Up,0.196203385473443,0.735762695525412
221,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.198042860536709,0.739155785074255
222,WP_RETINOL_METABOLISM,5,Down,0.200131754329764,0.739155785074255
223,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Down,0.203001597287498,0.739155785074255
224,WP_DNA_REPLICATION,34,Up,0.203017709932402,0.739155785074255
225,WP_STEROID_BIOSYNTHESIS,2,Down,0.205059654771057,0.739155785074255
226,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,47,Down,0.20555998945414,0.739155785074255
227,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,24,Down,0.205935287509304,0.739155785074255
228,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,10,Up,0.206913890314959,0.739155785074255
229,WP_TRYPTOPHAN_METABOLISM,17,Up,0.207601480429006,0.739155785074255
230,WP_HEART_DEVELOPMENT,15,Down,0.208174936824196,0.739155785074255
231,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,18,Down,0.208770387851959,0.739155785074255
232,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Down,0.210001912201837,0.739155785074255
233,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,50,Down,0.210124474703922,0.739155785074255
234,WP_TGFBETA_RECEPTOR_SIGNALING,34,Down,0.211684874053416,0.739155785074255
235,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.212803498013878,0.739155785074255
236,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,0.214087296818852,0.739155785074255
237,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.214470523290582,0.739155785074255
238,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,0.215253276659499,0.739155785074255
239,WP_METABOLIC_EPILEPTIC_DISORDERS,57,Down,0.215569955034801,0.739155785074255
240,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,23,Down,0.216871670225068,0.739155785074255
241,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.217469183745315,0.739155785074255
242,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,95,Down,0.218280739024066,0.739155785074255
243,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Down,0.21838610787123,0.739155785074255
244,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.218610923100749,0.739155785074255
245,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.220519039200975,0.742564111595119
246,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,47,Down,0.221630687479069,0.743273647033464
247,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Up,0.22431493196105,0.746638386707293
248,WP_GLUCURONIDATION,7,Up,0.224861151006584,0.746638386707293
249,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,17,Down,0.225349040351656,0.746638386707293
250,WP_APOPTOSIS,69,Up,0.228360474515837,0.752864424983868
251,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.229053297782971,0.752864424983868
252,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,87,Down,0.231029973228423,0.75634812664067
253,WP_LEPTIN_SIGNALING,70,Down,0.232692928683214,0.756464098446667
254,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.23289924970358,0.756464098446667
255,WP_BLOOD_CLOTTING_CASCADE,6,Up,0.234005540633409,0.757076749108087
256,WP_ALSTROM_SYNDROME,26,Down,0.235921098231816,0.759886762385565
257,WP_ESTROGEN_RECEPTOR_PATHWAY,9,Down,0.236716239918897,0.759886762385565
258,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,18,Down,0.238222099344131,0.761756713019024
259,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.240106632618759,0.763462092305849
260,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,9,Up,0.240606235150934,0.763462092305849
261,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,49,Down,0.243170574915491,0.767473834153361
262,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.243731084300825,0.767473834153361
263,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.246577603367117,0.7734848774824
264,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,19,Down,0.249041208979137,0.775406861720968
265,WP_UROTENSINIIMEDIATED_SIGNALING,48,Down,0.249070082855826,0.775406861720968
266,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,93,Down,0.25215295645742,0.777304356841944
267,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,8,Down,0.252408861095432,0.777304356841944
268,WP_THERMOGENESIS,75,Down,0.252506142586232,0.777304356841944
269,WP_SLEEP_REGULATION,10,Down,0.254349088817686,0.778063124553437
270,WP_IRON_METABOLISM_IN_PLACENTA,9,Down,0.256973369702432,0.778063124553437
271,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.259173510133855,0.778063124553437
272,WP_PROSTAGLANDIN_SIGNALING,24,Down,0.259936835037913,0.778063124553437
273,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Down,0.260047800483046,0.778063124553437
274,WP_MATRIX_METALLOPROTEINASES,10,Up,0.260147739164683,0.778063124553437
275,WP_WNT_SIGNALING_AND_PLURIPOTENCY,58,Down,0.262682622743491,0.778063124553437
276,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.262857937163054,0.778063124553437
277,WP_SPINA_BIFIDA,10,Down,0.263007687162059,0.778063124553437
278,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Up,0.263447894375546,0.778063124553437
279,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,45,Down,0.263947040334606,0.778063124553437
280,WP_REGULATION_OF_ACTIN_CYTOSKELETON,88,Down,0.265677337098919,0.778063124553437
281,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.268314964785017,0.778063124553437
282,WP_NUCLEAR_RECEPTORS,21,Down,0.271384450409239,0.778063124553437
283,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,47,Up,0.272094455574671,0.778063124553437
284,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Down,0.272194655243853,0.778063124553437
285,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.274252210072962,0.778063124553437
286,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,16,Down,0.27452630897639,0.778063124553437
287,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.275643206172437,0.778063124553437
288,WP_ENDOTHELIN_PATHWAYS,12,Up,0.276585319857267,0.778063124553437
289,WP_MONOAMINE_GPCRS,4,Down,0.276788308285106,0.778063124553437
290,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,8,Down,0.277623792986288,0.778063124553437
291,WP_FOLATE_METABOLISM,36,Down,0.278031845646218,0.778063124553437
292,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.278943213436019,0.778063124553437
293,WP_NAD_BIOSYNTHETIC_PATHWAYS,18,Down,0.280198575134316,0.778063124553437
294,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,23,Down,0.282002069610599,0.778063124553437
295,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,33,Down,0.282756036566076,0.778063124553437
296,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,35,Down,0.283011027075646,0.778063124553437
297,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.283158033151753,0.778063124553437
298,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.283810963721424,0.778063124553437
299,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.285764921778058,0.778063124553437
300,WP_GLUTATHIONE_METABOLISM,10,Up,0.286503325137412,0.778063124553437
301,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.286840832520208,0.778063124553437
302,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,38,Up,0.286897526702338,0.778063124553437
303,WP_METHYLATION_PATHWAYS,5,Up,0.287708641945445,0.778063124553437
304,WP_METASTATIC_BRAIN_TUMOR,6,Up,0.28867622533898,0.778063124553437
305,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,11,Up,0.288697560734827,0.778063124553437
306,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.289675260425699,0.778063124553437
307,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,86,Down,0.289853434317098,0.778063124553437
308,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,68,Down,0.290831849603004,0.778063124553437
309,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.291420006650924,0.778063124553437
310,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,1,Down,0.293915896250664,0.782195530344509
311,WP_LUNG_PATHOLOGY_OF_COVID19,16,Down,0.299382569962344,0.791199419143953
312,WP_IL26_SIGNALING,33,Down,0.30131331513602,0.791199419143953
313,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.301752713018102,0.791199419143953
314,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Up,0.302524589870013,0.791199419143953
315,WP_AEROBIC_GLYCOLYSIS,9,Down,0.303053353272108,0.791199419143953
316,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,9,Down,0.303053353272108,0.791199419143953
317,WP_AMINO_ACID_METABOLISM,57,Down,0.305972187771262,0.793969302457142
318,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Up,0.30603907658348,0.793969302457142
319,WP_IL11_SIGNALING,39,Down,0.309867684399461,0.801381942412399
320,WP_CILIARY_LANDSCAPE,180,Down,0.312735676534842,0.80627166606639
321,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,26,Up,0.316411656608929,0.806572105640087
322,WP_GALANIN_RECEPTOR_PATHWAY,11,Down,0.316886700045647,0.806572105640087
323,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.316912317510358,0.806572105640087
324,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,42,Down,0.317448719285201,0.806572105640087
325,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Up,0.31819027654218,0.806572105640087
326,WP_ESTROGEN_METABOLISM_WP697,6,Down,0.318792263459568,0.806572105640087
327,WP_RAC1PAK1P38MMP2_PATHWAY,52,Down,0.319769414053632,0.806572105640087
328,WP_RETT_SYNDROME,30,Down,0.320673515939332,0.806572105640087
329,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,34,Down,0.324276691601179,0.809271047322204
330,WP_NPHP1_DELETION_SYNDROME,10,Down,0.324660235592807,0.809271047322204
331,WP_EICOSANOID_SYNTHESIS,13,Down,0.325623632926718,0.809271047322204
332,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Down,0.326097316946265,0.809271047322204
333,WP_ARYLAMINE_METABOLISM,1,Up,0.326947456996013,0.809271047322204
334,WP_PROXIMAL_TUBULE_TRANSPORT,25,Up,0.327632157340141,0.809271047322204
335,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,15,Down,0.331156750004626,0.813809215490944
336,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.331729743573547,0.813809215490944
337,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,40,Down,0.332428734085392,0.813809215490944
338,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Down,0.335453645712434,0.817164928653345
339,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,5,Down,0.335837822636219,0.817164928653345
340,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Down,0.337698888978194,0.817164928653345
341,WP_ESTROGEN_SIGNALING,21,Down,0.338687277010363,0.817164928653345
342,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Up,0.339252480740836,0.817164928653345
343,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Down,0.339742509731027,0.817164928653345
344,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,38,Down,0.34462839410859,0.82566394472325
345,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.345389434283448,0.82566394472325
346,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.346278454393024,0.82566394472325
347,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Up,0.350120706921276,0.826572523523629
348,WP_IL5_SIGNALING,37,Down,0.352144356401181,0.826572523523629
349,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Down,0.35257042964493,0.826572523523629
350,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.353141462222029,0.826572523523629
351,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.353629531174644,0.826572523523629
352,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.354395901502431,0.826572523523629
353,WP_VITAMIN_A1_AND_A5X_PATHWAYS,4,Down,0.354549586573409,0.826572523523629
354,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Up,0.354711847877989,0.826572523523629
355,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,20,Up,0.356555710994994,0.826572523523629
356,WP_ATM_SIGNALING,32,Down,0.357095071759909,0.826572523523629
357,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.358209264839124,0.826572523523629
358,WP_CYTOSINE_METHYLATION,7,Down,0.35943081347458,0.826572523523629
359,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.359684285993919,0.826572523523629
360,WP_AFLATOXIN_B1_METABOLISM,2,Down,0.361753967866417,0.829019509693873
361,WP_MESODERMAL_COMMITMENT_PATHWAY,74,Down,0.36507399599429,0.833027732361944
362,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,15,Up,0.365522471654574,0.833027732361944
363,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Up,0.369782745625078,0.835175096341493
364,WP_BENZENE_METABOLISM,3,Down,0.37044451025208,0.835175096341493
365,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.370479716150564,0.835175096341493
366,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,11,Down,0.370741910331089,0.835175096341493
367,WP_CHOLESTEROL_METABOLISM,49,Down,0.371526376190701,0.835175096341493
368,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Down,0.373293276691914,0.836761201658888
369,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.378746666578225,0.836761201658888
370,WP_CAMKK2_PATHWAY,29,Down,0.378856681037983,0.836761201658888
371,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.381509365578555,0.836761201658888
372,WP_NOTCH_SIGNALING_WP268,33,Down,0.381789498190493,0.836761201658888
373,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.382135579016911,0.836761201658888
374,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Up,0.382200325433167,0.836761201658888
375,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,81,Down,0.383233389840461,0.836761201658888
376,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.383378886971858,0.836761201658888
377,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.383869988941947,0.836761201658888
378,WP_MRNA_PROCESSING,124,Down,0.384206779776314,0.836761201658888
379,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,28,Down,0.384474912142732,0.836761201658888
380,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,2,Up,0.385900631476692,0.836761201658888
381,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,80,Down,0.388850919872477,0.836761201658888
382,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Down,0.395685897934786,0.836761201658888
383,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Down,0.395958440642588,0.836761201658888
384,WP_13Q1212_COPY_NUMBER_VARIATION,17,Down,0.39722110094381,0.836761201658888
385,WP_FERROPTOSIS,48,Up,0.397302604067992,0.836761201658888
386,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.398439981115903,0.836761201658888
387,WP_HEME_BIOSYNTHESIS,8,Up,0.398439981115903,0.836761201658888
388,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.400071056064472,0.836761201658888
389,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,164,Down,0.400604519998556,0.836761201658888
390,WP_SPHINGOLIPID_PATHWAY,21,Up,0.400806097463354,0.836761201658888
391,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Down,0.400821145561872,0.836761201658888
392,WP_NANOMATERIAL_INDUCED_APOPTOSIS,17,Up,0.401084225494907,0.836761201658888
393,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.402709960923829,0.836761201658888
394,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.404192893457596,0.836761201658888
395,WP_VITAMIN_B12_METABOLISM,24,Down,0.404667442970209,0.836761201658888
396,WP_BENZOAPYRENE_METABOLISM,4,Down,0.405248143821181,0.836761201658888
397,WP_BREAST_CANCER_PATHWAY,82,Down,0.405928211527403,0.836761201658888
398,WP_OSTEOCLAST_SIGNALING,9,Up,0.407244420468869,0.836761201658888
399,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.407375916004025,0.836761201658888
400,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,3,Up,0.407692786945545,0.836761201658888
401,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.408804505452299,0.836761201658888
402,WP_PYRIMIDINE_METABOLISM,71,Up,0.409602980378837,0.836761201658888
403,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.409747915276118,0.836761201658888
404,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.409759424812352,0.836761201658888
405,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.412179431463295,0.838015878559783
406,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,9,Down,0.412405389933663,0.838015878559783
407,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,10,Up,0.414021301639551,0.839232368188279
408,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,47,Down,0.419634412614135,0.845774154478764
409,WP_HUNGER_AND_SATIETY,2,Up,0.419744383340687,0.845774154478764
410,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.420766061738103,0.845774154478764
411,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.422735697046251,0.845774154478764
412,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.423526555318995,0.845774154478764
413,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Up,0.424179595770399,0.845774154478764
414,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,112,Up,0.42502714284505,0.845774154478764
415,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.425803919687009,0.845774154478764
416,WP_PDGFRBETA_PATHWAY,27,Up,0.426623863065359,0.845774154478764
417,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,49,Down,0.428014271948492,0.845774154478764
418,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,51,Down,0.429867962415634,0.845774154478764
419,WP_ENDOCHONDRAL_OSSIFICATION,26,Down,0.430575933189189,0.845774154478764
420,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Down,0.430575933189189,0.845774154478764
421,WP_OVARIAN_INFERTILITY,21,Down,0.432707369747307,0.845968423964801
422,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.434855746283745,0.845968423964801
423,WP_DISORDERS_IN_KETOLYSIS,3,Up,0.435233475061038,0.845968423964801
424,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.4355215264322,0.845968423964801
425,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.435801915375807,0.845968423964801
426,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Down,0.441657375220091,0.854557183424513
427,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.443596791140489,0.854557183424513
428,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.443817819262809,0.854557183424513
429,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Down,0.448234773536217,0.854557183424513
430,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,76,Down,0.449290651300728,0.854557183424513
431,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.450313172226385,0.854557183424513
432,WP_IL2_SIGNALING,37,Down,0.450323109024204,0.854557183424513
433,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.450872206737623,0.854557183424513
434,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,42,Down,0.451611467605386,0.854557183424513
435,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.451990739434048,0.854557183424513
436,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.452295307243453,0.854557183424513
437,WP_ACUTE_MYELOID_LEUKEMIA,56,Up,0.453628454009894,0.854557183424513
438,WP_WNT_SIGNALING_WP363,40,Down,0.453692177381742,0.854557183424513
439,WP_16P112_PROXIMAL_DELETION_SYNDROME,61,Down,0.457065238382836,0.855658216704724
440,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.457067632478755,0.855658216704724
441,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,16,Down,0.459848266662437,0.855658216704724
442,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.459959186647808,0.855658216704724
443,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,28,Down,0.460109354678582,0.855658216704724
444,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.461394506898177,0.855658216704724
445,WP_ECTODERM_DIFFERENTIATION,72,Up,0.461536856283154,0.855658216704724
446,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.464215602511457,0.858694780430385
447,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.466992570843348,0.861094290794226
448,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Down,0.467600293667652,0.861094290794226
449,WP_IDO_METABOLIC_PATHWAY,6,Up,0.470423843360329,0.861965166893786
450,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Down,0.470726439423504,0.861965166893786
451,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.474009181691413,0.861965166893786
452,WP_PPAR_SIGNALING,37,Down,0.474679342306917,0.861965166893786
453,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.474690837577511,0.861965166893786
454,WP_DRAVET_SYNDROME,12,Down,0.474975526495698,0.861965166893786
455,WP_PRIMARY_OVARIAN_INSUFFICIENCY,87,Down,0.478297532371627,0.861965166893786
456,WP_WNT_SIGNALING_WP428,58,Down,0.478569662452238,0.861965166893786
457,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.478955828462098,0.861965166893786
458,WP_HEDGEHOG_SIGNALING_WP4249,25,Down,0.479347572381022,0.861965166893786
459,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,44,Down,0.479566074671815,0.861965166893786
460,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,12,Down,0.482337727114785,0.865062227977604
461,WP_SMALL_LIGAND_GPCRS,7,Down,0.486814612853195,0.870804694058239
462,WP_DNA_MISMATCH_REPAIR,21,Up,0.487853707370568,0.870804694058239
463,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.488706149513897,0.870804694058239
464,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.495106156950277,0.874283317208386
465,WP_INTEGRINMEDIATED_CELL_ADHESION,70,Down,0.495152819232824,0.874283317208386
466,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,33,Down,0.495267812960811,0.874283317208386
467,WP_IL19_SIGNALING,20,Down,0.496443283497461,0.874283317208386
468,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.496788023572588,0.874283317208386
469,WP_15Q11Q13_COPY_NUMBER_VARIATION,28,Up,0.497839983061565,0.874283317208386
470,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.498076556470232,0.874283317208386
471,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,10,Down,0.499681888302363,0.874537480291563
472,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.501321142512015,0.874537480291563
473,WP_HISTONE_MODIFICATIONS,35,Up,0.501401488700496,0.874537480291563
474,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.504538945728846,0.875008435258869
475,WP_SEROTONIN_AND_ANXIETY,6,Down,0.505499687568008,0.875008435258869
476,WP_OSTEOPONTIN_SIGNALING,12,Down,0.505520136447623,0.875008435258869
477,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,23,Up,0.507280005855204,0.875008435258869
478,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,60,Down,0.509733196349916,0.875008435258869
479,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,14,Down,0.509943099991154,0.875008435258869
480,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,27,Down,0.510137380958984,0.875008435258869
481,WP_PRION_DISEASE_PATHWAY,29,Down,0.51015643316305,0.875008435258869
482,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.513536151874856,0.876762228379582
483,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Up,0.516282089094708,0.876762228379582
484,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.517313664058219,0.876762228379582
485,WP_ETHER_LIPID_BIOSYNTHESIS,15,Down,0.518795579553274,0.876762228379582
486,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Up,0.519492924037465,0.876762228379582
487,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.519625631302686,0.876762228379582
488,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,9,Down,0.520009548247795,0.876762228379582
489,WP_FLUOROPYRIMIDINE_ACTIVITY,26,Up,0.520375646900645,0.876762228379582
490,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,20,Down,0.52151671704601,0.876762228379582
491,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.521806368647727,0.876762228379582
492,WP_MINERALOCORTICOID_BIOSYNTHESIS,2,Up,0.52390896667295,0.877841986461727
493,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.524577090091674,0.877841986461727
494,WP_IL7_SIGNALING,24,Down,0.530215537131873,0.880597779735595
495,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,27,Down,0.530678314442318,0.880597779735595
496,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,18,Up,0.531235771291962,0.880597779735595
497,WP_FOXP3_IN_COVID19,9,Down,0.531840637093321,0.880597779735595
498,WP_LEPTININSULIN_SIGNALING_OVERLAP,12,Down,0.532164216031601,0.880597779735595
499,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.533485658965038,0.880597779735595
500,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,8,Up,0.533695624082179,0.880597779735595
501,WP_ESTROGEN_METABOLISM_WP5276,9,Up,0.535847964417733,0.881350373905171
502,WP_MACROPHAGE_MARKERS,8,Down,0.537174877170806,0.881350373905171
503,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.537356652211274,0.881350373905171
504,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Down,0.541211302369787,0.882489316540229
505,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.541610228886062,0.882489316540229
506,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.542070262590139,0.882489316540229
507,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,42,Down,0.542329798164723,0.882489316540229
508,WP_SERINE_METABOLISM,7,Up,0.543608675713163,0.882829050124723
509,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,11,Down,0.546907719055794,0.886441784324224
510,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.550429751827381,0.890401069132527
511,WP_ADIPOGENESIS,80,Up,0.551732283938858,0.890761515165476
512,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Down,0.553579160673046,0.891925358576692
513,WP_BLADDER_CANCER,30,Down,0.557221559424897,0.891925358576692
514,WP_FOXA2_PATHWAY,9,Down,0.557723278283637,0.891925358576692
515,WP_HIPPOYAP_SIGNALING,15,Down,0.557918137805894,0.891925358576692
516,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.558179009932839,0.891925358576692
517,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,6,Down,0.559463368827674,0.891925358576692
518,WP_NEPHROGENESIS,3,Down,0.560021013021487,0.891925358576692
519,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.563714787405241,0.896078419285787
520,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.564850881129976,0.896157647946596
521,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,133,Down,0.567919105926522,0.899296089039119
522,WP_CANCER_PATHWAYS,292,Down,0.571376072270579,0.900674898614056
523,WP_NEUROINFLAMMATION,10,Down,0.573053905380353,0.900674898614056
524,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,11,Down,0.573404193526463,0.900674898614056
525,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.573832357856086,0.900674898614056
526,WP_COMPLEMENT_AND_COAGULATION_CASCADES,24,Up,0.575340207963161,0.900674898614056
527,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,24,Up,0.575340207963161,0.900674898614056
528,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.577636582570519,0.902418121711925
529,WP_VITAMIN_D_RECEPTOR_PATHWAY,82,Down,0.578641438043162,0.902418121711925
530,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.580235450501271,0.903196691818016
531,WP_TCA_CYCLE_IN_SENESCENCE,9,Down,0.582103947497634,0.903940563892583
532,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,46,Down,0.583405804988333,0.903940563892583
533,WP_TNFALPHA_SIGNALING,81,Down,0.584362219528292,0.903940563892583
534,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,43,Down,0.585167834611886,0.903940563892583
535,WP_SMALL_CELL_LUNG_CANCER,64,Down,0.58619175961519,0.903940563892583
536,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,16,Down,0.591030461969886,0.907619623731729
537,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,16,Down,0.59155785684789,0.907619623731729
538,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.592630409592822,0.907619623731729
539,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,50,Down,0.594477532408647,0.907619623731729
540,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,11,Up,0.59470934579599,0.907619623731729
541,WP_LUNG_FIBROSIS,35,Down,0.595178444168322,0.907619623731729
542,WP_TGFB_SMAD_SIGNALING,6,Up,0.598376520671457,0.910249363339997
543,WP_ULCERATIVE_COLITIS_SIGNALING,13,Down,0.599109580961961,0.910249363339997
544,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.600996741804761,0.911438073509059
545,WP_SULFATASE_AND_AROMATASE_PATHWAY,3,Down,0.604543657784676,0.911929613373059
546,WP_NEOVASCULARIZATION_PROCESSES,23,Down,0.605987789843278,0.911929613373059
547,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Up,0.607798764980828,0.911929613373059
548,WP_ENDOMETRIAL_CANCER,48,Down,0.6089699161532,0.911929613373059
549,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,10,Down,0.61006773157035,0.911929613373059
550,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,4,Down,0.61337630700444,0.911929613373059
551,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.613541706763532,0.911929613373059
552,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,80,Down,0.613601881079074,0.911929613373059
553,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.614322509338537,0.911929613373059
554,WP_OPIOID_RECEPTOR_PATHWAYS,25,Up,0.615741325583062,0.911929613373059
555,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,4,Up,0.618793600331983,0.911929613373059
556,WP_GLYCOSPHINGOLIPID_METABOLISM,12,Up,0.619300699674799,0.911929613373059
557,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.619471494142646,0.911929613373059
558,WP_LIPID_PARTICLES_COMPOSITION,4,Up,0.621986907702218,0.911929613373059
559,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,13,Up,0.622136547613578,0.911929613373059
560,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.623191140600551,0.911929613373059
561,WP_ACUTE_VIRAL_MYOCARDITIS,66,Up,0.624089521728053,0.911929613373059
562,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.624260010580062,0.911929613373059
563,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.625062782089758,0.911929613373059
564,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.625856598070979,0.911929613373059
565,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,58,Down,0.626020504176613,0.911929613373059
566,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.627381154925808,0.911929613373059
567,WP_NUCLEAR_RECEPTORS_METAPATHWAY,174,Down,0.628531046593635,0.911929613373059
568,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,63,Down,0.629921649356657,0.911929613373059
569,WP_MELANOMA,53,Down,0.630520264166539,0.911929613373059
570,WP_NOTCH_SIGNALING_WP61,48,Up,0.631598799721151,0.911929613373059
571,WP_OMEGA9_FATTY_ACID_SYNTHESIS,10,Down,0.631997352430465,0.911929613373059
572,WP_16P112_DISTAL_DELETION_SYNDROME,21,Down,0.632271198605321,0.911929613373059
573,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,47,Down,0.634397517012611,0.913399566379414
574,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.640066816677677,0.918282831038819
575,WP_ALZHEIMERS_DISEASE,183,Down,0.642972615237024,0.918282831038819
576,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,183,Down,0.642972615237024,0.918282831038819
577,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.643289496295285,0.918282831038819
578,WP_VITAMIN_D_METABOLISM,6,Down,0.644158655679075,0.918282831038819
579,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,65,Down,0.64536120528785,0.918282831038819
580,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.645580656972745,0.918282831038819
581,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.647240803038573,0.91905966008059
582,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.648738845977716,0.919604034246763
583,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.651673752510256,0.92217983845791
584,WP_TAR_SYNDROME,44,Down,0.654609158198552,0.922813185379349
585,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,18,Down,0.654759676572078,0.922813185379349
586,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,24,Down,0.655641583211492,0.922813185379349
587,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,13,Down,0.656913799495939,0.922813185379349
588,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Down,0.657941191757865,0.922813185379349
589,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.659142476189114,0.922813185379349
590,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,5,Down,0.659951247725837,0.922813185379349
591,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Down,0.664304152782718,0.925887749459874
592,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.664394603248783,0.925887749459874
593,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.665634951713751,0.926051998589957
594,WP_TYPE_II_DIABETES_MELLITUS,12,Down,0.667950116371455,0.927276478430534
595,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,11,Up,0.670346108394393,0.927276478430534
596,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,11,Up,0.672554989886655,0.927276478430534
597,WP_MELATONIN_METABOLISM_AND_EFFECTS,20,Up,0.672624610022465,0.927276478430534
598,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.673017590357965,0.927276478430534
599,WP_ANDROGEN_RECEPTOR_SIGNALING,78,Up,0.673258921915018,0.927276478430534
600,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.676864716454576,0.928939085225597
601,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,1,Up,0.676985605271229,0.928939085225597
602,WP_OSTEOBLAST_SIGNALING,2,Down,0.677844035522193,0.928939085225597
603,WP_PARKINSONS_DISEASE_PATHWAY,25,Down,0.679639535169348,0.929855085430701
604,WP_ENERGY_METABOLISM,41,Up,0.681666027100479,0.93005826214572
605,WP_NONSMALL_CELL_LUNG_CANCER,58,Down,0.682042725573528,0.93005826214572
606,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,38,Up,0.686595694047156,0.934345450112933
607,WP_BARDETBIEDL_SYNDROME,61,Up,0.687979033581114,0.934345450112933
608,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,41,Down,0.688584283234743,0.934345450112933
609,WP_NEPHROTIC_SYNDROME,26,Up,0.690515230065891,0.934521657538681
610,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Up,0.692277136705489,0.934521657538681
611,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.693196005674693,0.934521657538681
612,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,33,Up,0.698341574568105,0.934521657538681
613,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,6,Down,0.701100009411528,0.934521657538681
614,WP_IL9_SIGNALING,15,Down,0.702099783986549,0.934521657538681
615,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,25,Down,0.702771828321287,0.934521657538681
616,WP_ANGIOGENESIS,14,Down,0.704970090447878,0.934521657538681
617,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Up,0.705010781766489,0.934521657538681
618,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.706009917606659,0.934521657538681
619,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.706163863785332,0.934521657538681
620,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,61,Down,0.707365320433923,0.934521657538681
621,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,51,Up,0.707801793626116,0.934521657538681
622,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Up,0.707989729144775,0.934521657538681
623,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.709656253784827,0.934521657538681
624,WP_IL4_SIGNALING,50,Down,0.710247047539926,0.934521657538681
625,WP_MALE_INFERTILITY,71,Down,0.710292796025892,0.934521657538681
626,WP_10Q22Q23_COPY_NUMBER_VARIATION,26,Up,0.711020120947181,0.934521657538681
627,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.711105894542409,0.934521657538681
628,WP_CCL18_SIGNALING,23,Down,0.711369213253687,0.934521657538681
629,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.715545801461799,0.938178197666465
630,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.717564173003078,0.938178197666465
631,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.717564173003078,0.938178197666465
632,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,25,Down,0.720398185601442,0.938502867722168
633,WP_G13_SIGNALING,30,Down,0.721248513195597,0.938502867722168
634,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.72251225393914,0.938502867722168
635,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.722641749845522,0.938502867722168
636,WP_MEVALONATE_PATHWAY,7,Down,0.723500392571271,0.938502867722168
637,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.72541660986922,0.938891206754374
638,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,71,Down,0.726750771306511,0.938891206754374
639,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.729502821904244,0.938891206754374
640,WP_FATTY_ACID_BETAOXIDATION,28,Up,0.730353969417712,0.938891206754374
641,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Up,0.730532635636645,0.938891206754374
642,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.73062806634704,0.938891206754374
643,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,8,Up,0.733782470261389,0.940689675666509
644,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.73592637247385,0.940689675666509
645,WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION,1,Down,0.737534780389429,0.940689675666509
646,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,8,Up,0.737662686844907,0.940689675666509
647,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,27,Down,0.737728751704523,0.940689675666509
648,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,61,Down,0.741793899743908,0.942766367602047
649,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.742741779078878,0.942766367602047
650,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,7,Down,0.742959982767063,0.942766367602047
651,WP_CORI_CYCLE,11,Down,0.744618167205177,0.942766367602047
652,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.745773928197901,0.942766367602047
653,WP_GLUCOCORTICOID_BIOSYNTHESIS,3,Up,0.749644285855909,0.942766367602047
654,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,7,Down,0.750106631761658,0.942766367602047
655,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,7,Down,0.750106631761658,0.942766367602047
656,WP_RETINOBLASTOMA_GENE_IN_CANCER,65,Up,0.750780398348928,0.942766367602047
657,WP_INFLAMMATORY_RESPONSE_PATHWAY,13,Down,0.75222691869645,0.942766367602047
658,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,120,Down,0.753138604992244,0.942766367602047
659,WP_SILDENAFIL_TREATMENT,11,Down,0.754666524171866,0.942766367602047
660,WP_GLYOXYLATE_METABOLISM,5,Up,0.755525697563348,0.942766367602047
661,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Down,0.756097063210891,0.942766367602047
662,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Up,0.757578477678994,0.942766367602047
663,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,14,Up,0.75862868022158,0.942766367602047
664,WP_KREBS_CYCLE_DISORDERS,11,Down,0.758784082530617,0.942766367602047
665,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,32,Up,0.761208571438156,0.94317533124486
666,WP_CELL_CYCLE,87,Down,0.762009240292119,0.94317533124486
667,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,17,Up,0.762873888026894,0.94317533124486
668,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,5,Up,0.766609053863482,0.94317533124486
669,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Up,0.766945979069933,0.94317533124486
670,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Down,0.767545114496245,0.94317533124486
671,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.767837197549415,0.94317533124486
672,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.771784156535856,0.94317533124486
673,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Down,0.771850323271452,0.94317533124486
674,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,8,Up,0.772076322672881,0.94317533124486
675,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.775053502704854,0.94317533124486
676,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,22,Down,0.77587105832796,0.94317533124486
677,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Up,0.776446025667206,0.94317533124486
678,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Down,0.777222728100853,0.94317533124486
679,WP_15Q25_COPY_NUMBER_VARIATION,26,Down,0.779262600295454,0.94317533124486
680,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,268,Down,0.781027277715233,0.94317533124486
681,WP_LEPTIN_AND_ADIPONECTIN,8,Up,0.781108040070769,0.94317533124486
682,WP_APOPTOSIS_MODULATION_AND_SIGNALING,73,Up,0.782915842047764,0.94317533124486
683,WP_BASE_EXCISION_REPAIR,29,Up,0.78409087282753,0.94317533124486
684,WP_IL3_SIGNALING,45,Down,0.784398550377181,0.94317533124486
685,WP_PI3KAKT_SIGNALING,174,Down,0.785298077488789,0.94317533124486
686,WP_PAFAH1B1_COPY_NUMBER_VARIATION,8,Down,0.785381793641908,0.94317533124486
687,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,28,Up,0.785407821291175,0.94317533124486
688,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Down,0.786906352544138,0.943601367512956
689,WP_ONECARBON_METABOLISM,22,Down,0.790811854680435,0.944976331497767
690,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,46,Down,0.792953967958573,0.944976331497767
691,WP_G1_TO_S_CELL_CYCLE_CONTROL,48,Up,0.793167356436918,0.944976331497767
692,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.794241104402421,0.944976331497767
693,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,53,Down,0.795702425063297,0.944976331497767
694,WP_AUTOPHAGY,27,Down,0.797575199890871,0.944976331497767
695,WP_PPARALPHA_PATHWAY,15,Up,0.798642597657508,0.944976331497767
696,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,64,Up,0.799298506794889,0.944976331497767
697,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Up,0.801681887862364,0.944976331497767
698,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,36,Up,0.802584143418054,0.944976331497767
699,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,46,Up,0.803909716561879,0.944976331497767
700,WP_COMPLEMENT_SYSTEM,52,Down,0.806803037688533,0.944976331497767
701,WP_GASTRIC_CANCER_NETWORK_1,16,Up,0.807694181479274,0.944976331497767
702,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,6,Up,0.809325246383253,0.944976331497767
703,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.810771927049334,0.944976331497767
704,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Up,0.811284023507133,0.944976331497767
705,WP_CHOLESTASIS,9,Up,0.811392979952294,0.944976331497767
706,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,11,Down,0.811592258369669,0.944976331497767
707,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.813482720097468,0.944976331497767
708,WP_HEPATITIS_B_INFECTION,118,Down,0.813814547208095,0.944976331497767
709,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Up,0.81389951785606,0.944976331497767
710,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.81406676055494,0.944976331497767
711,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,40,Up,0.814397783872621,0.944976331497767
712,WP_JOUBERT_SYNDROME,66,Up,0.816866727738978,0.94524151991513
713,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.817247310012052,0.94524151991513
714,WP_SECRETION_OF_HYDROCHLORIC_ACID_IN_PARIETAL_CELLS,1,Up,0.818063569962912,0.94524151991513
715,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,19,Up,0.819409505530037,0.945472506380812
716,WP_TOLLLIKE_RECEPTOR_SIGNALING,80,Up,0.824819238421534,0.946871814734407
717,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.825067662842134,0.946871814734407
718,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.827605043164299,0.946871814734407
719,WP_EFFECTS_OF_MFN2_MUTATION,17,Up,0.828423891424438,0.946871814734407
720,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,39,Down,0.828599055337188,0.946871814734407
721,WP_PHOSPHOINOSITIDES_METABOLISM,37,Up,0.832059329017981,0.946871814734407
722,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Down,0.832081071585319,0.946871814734407
723,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,49,Up,0.832161349486225,0.946871814734407
724,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Down,0.832850444980155,0.946871814734407
725,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,19,Down,0.833611266777384,0.946871814734407
726,WP_IL6_SIGNALING,39,Down,0.834258844974888,0.946871814734407
727,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,30,Up,0.834394920378077,0.946871814734407
728,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Down,0.838354773732795,0.948320387928715
729,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,20,Up,0.838638054779595,0.948320387928715
730,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,20,Down,0.839119858409651,0.948320387928715
731,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,20,Up,0.841069213676213,0.949223120770007
732,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.84673439925451,0.952869407738109
733,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.847590144087699,0.952869407738109
734,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,8,Down,0.849292665775464,0.952869407738109
735,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.850291867353043,0.952869407738109
736,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,55,Up,0.851742189674044,0.952869407738109
737,WP_P38_MAPK_SIGNALING,31,Down,0.852978659152953,0.952869407738109
738,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.853257711363529,0.952869407738109
739,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.853539990689046,0.952869407738109
740,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.855928671038475,0.954244802171273
741,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.85963440775536,0.955292835003162
742,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.860014885699181,0.955292835003162
743,WP_NUCLEOTIDE_GPCRS,7,Down,0.861725944498581,0.955292835003162
744,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Down,0.862101875828912,0.955292835003162
745,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,17,Down,0.862658378275583,0.955292835003162
746,WP_WHITE_FAT_CELL_DIFFERENTIATION,22,Up,0.86412683309478,0.955636243033771
747,WP_NRF2_PATHWAY,69,Up,0.86672608099695,0.957227599494624
748,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,5,Down,0.86792579518345,0.957271097628806
749,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,2,Up,0.872741763305745,0.959140923989358
750,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Up,0.872741763305745,0.959140923989358
751,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,8,Down,0.873108889595161,0.959140923989358
752,WP_KALLMANN_SYNDROME,11,Up,0.877260916168428,0.961027661265272
753,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.877415579105428,0.961027661265272
754,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.879980180573808,0.961027661265272
755,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,25,Down,0.880636329199993,0.961027661265272
756,WP_GASTRIC_CANCER_NETWORK_2,25,Down,0.880650802323086,0.961027661265272
757,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.882578318805727,0.961718691853049
758,WP_IRON_METABOLISM_DISORDERS,12,Down,0.883615476878316,0.961718691853049
759,WP_CIRCADIAN_RHYTHM_GENES,113,Down,0.884922595348803,0.961872386248699
760,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,24,Down,0.886277534752203,0.962077587066536
761,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Up,0.889131270060931,0.962916015238802
762,WP_TAMOXIFEN_METABOLISM,3,Down,0.890855542693469,0.962916015238802
763,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.892011132021177,0.962916015238802
764,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.892952192264867,0.962916015238802
765,WP_KININKALLIKREIN_PATHWAY,2,Down,0.894065276294482,0.962916015238802
766,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,43,Up,0.89470734946475,0.962916015238802
767,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,39,Up,0.895220101440195,0.962916015238802
768,WP_TCELL_ACTIVATION_SARSCOV2,60,Down,0.897626306960859,0.963631095791997
769,WP_CELLULAR_PROTEOSTASIS,6,Down,0.898220985047328,0.963631095791997
770,WP_4P163_COPY_NUMBER_VARIATION,21,Down,0.900397808676981,0.964711937868194
771,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Up,0.902786433614392,0.966016611844194
772,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,24,Down,0.908219929980432,0.969344248378573
773,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,15,Up,0.908894488767084,0.969344248378573
774,WP_SYNAPTIC_VESICLE_PATHWAY,20,Up,0.911380422877055,0.969344248378573
775,WP_PTF1A_RELATED_REGULATORY_PATHWAY,4,Down,0.912894883325823,0.969344248378573
776,WP_PANCREATIC_CANCER_SUBTYPES,4,Down,0.913146982883687,0.969344248378573
777,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Down,0.913809956170048,0.969344248378573
778,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.91494621552549,0.969344248378573
779,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.915295963014435,0.969344248378573
780,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.918919201092545,0.970051606228502
781,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.919457341484133,0.970051606228502
782,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,7,Down,0.919491340691744,0.970051606228502
783,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,36,Down,0.926470081616855,0.976165794807032
784,WP_EBOLA_VIRUS_INFECTION_IN_HOST,108,Down,0.929353018194328,0.977431989861004
785,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.930217939456175,0.977431989861004
786,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,5,Up,0.931226113976666,0.977431989861004
787,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Down,0.933519043349042,0.978123550903123
788,WP_IL17_SIGNALING,24,Up,0.935502062558547,0.978123550903123
789,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.938510009730827,0.978123550903123
790,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Up,0.939353818412652,0.978123550903123
791,WP_HOMOLOGOUS_RECOMBINATION,11,Up,0.939903854165447,0.978123550903123
792,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,60,Up,0.940122252537699,0.978123550903123
793,WP_CILIOPATHIES,114,Up,0.940184213171123,0.978123550903123
794,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.942242889147765,0.979030709756808
795,WP_GLYCOLYSIS_IN_SENESCENCE,10,Down,0.944565993426176,0.979541010803275
796,WP_TRANSSULFURATION_PATHWAY,8,Down,0.945108660120493,0.979541010803275
797,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,16,Up,0.947201055987827,0.979717852249933
798,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.94781063400019,0.979717852249933
799,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,14,Up,0.948841895694178,0.979717852249933
800,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Up,0.950773736244607,0.980485415502251
801,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Down,0.954302754130607,0.982896095078341
802,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,54,Down,0.956657115410608,0.983883366440053
803,WP_ID_SIGNALING,11,Down,0.957646476668318,0.983883366440053
804,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,26,Down,0.961487164897056,0.986600635621979
805,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.9627792706504,0.986699252529913
806,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.965223883149926,0.987302472035532
807,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,69,Down,0.96576132719112,0.987302472035532
808,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,54,Down,0.969310240754248,0.989192853449246
809,WP_SULINDAC_METABOLIC_PATHWAY,3,Down,0.970008507200533,0.989192853449246
810,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.97477716774256,0.992828596774829
811,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.978253412363206,0.994116026934617
812,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,57,Down,0.978451168328374,0.994116026934617
813,WP_INTEGRATED_CANCER_PATHWAY,37,Down,0.980701770014964,0.995177072893414
814,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.984295066472633,0.997596351154696
815,WP_DNA_DAMAGE_RESPONSE,56,Down,0.987999970106093,0.997631260103011
816,WP_FOCAL_ADHESION,117,Up,0.989612389323011,0.997631260103011
817,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,20,Up,0.991112889375984,0.997631260103011
818,WP_PROTEASOME_DEGRADATION,57,Down,0.991242516417689,0.997631260103011
819,WP_MIRNA_BIOGENESIS,6,Down,0.991507078339694,0.997631260103011
820,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.992252271177437,0.997631260103011
821,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Down,0.99477564615497,0.997631260103011
822,WP_PEPTIDE_GPCRS,14,Down,0.995105251554578,0.997631260103011
823,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,39,Up,0.995212760078519,0.997631260103011
824,WP_SELENIUM_MICRONUTRIENT_NETWORK,50,Down,0.997055627749627,0.997861875488112
825,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,19,Down,0.997861875488112,0.997861875488112
